Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H-2 class I histocompatibility antigen, K-D alpha chain (H2-Kd) is a polymorphic protein belonging to the Major Histocompatibility Complex (MHC) class I family in mice, specifically found in the d-haplotype such as in BALB/c strains (UniProt: P01901). It functions as a heterodimer with beta-2 microglobulin to present short intracellular peptides, typically 8-10 amino acids in length, to the T-cell receptors (TCRs) of CD8+ cytotoxic T lymphocytes (Janeway's Immunobiology). On dendritic cells, H2-Kd is pivotal for the initiation of the adaptive immune response, as these cells are uniquely capable of cross-presenting exogenous antigens on MHC class I molecules to prime naive T cells (Nature, 1998, 392:245-252). This molecule is a cornerstone of preclinical immunology research, serving as a target for evaluating peptide vaccines, TCR-engineered T cells, and monoclonal antibodies in mouse models of cancer and infectious disease (J. Immunol., 2005, 174:6712-6719). Therapeutic strategies often focus on loading H2-Kd with specific tumor-associated or viral antigens to elicit a robust cellular immune response. However, targeting MHC molecules requires high specificity to avoid off-target autoimmune reactions or systemic inflammatory responses.
Presentation of intracellularly processed antigenic peptides to the T-cell receptor (TCR) of CD8+ cytotoxic T lymphocytes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H-2 class I histocompatibility antigen, K-D alpha chain (H2-Kd).